Navigation Links
Studies on Urgent(R) PC to be Presented at the 2008 Society of Urologic Nurses and Associates Annual Symposium

MINNEAPOLIS, Feb. 11 /PRNewswire-FirstCall/ -- Uroplasty, Inc. (Amex: UPI), a medical device company that develops, manufactures and markets innovative proprietary products for the treatment of voiding dysfunction, announced today that the Urgent(R) PC Neuromodulation System, its proprietary, minimally invasive nerve stimulation device, designed for office-based treatment of overactive bladder (OAB) symptoms, will be featured in three presentations at the Society of Urologic Nurses and Associates (SUNA) Annual Symposium. SUNA will be held at the Marriott Waterside Hotel and Marina in Tampa, Florida from Thursday, February 28, through Sunday, March 2. These retrospective and observational studies examined the use of Urgent(R) PC Neuromodulation System to deliver the percutaneous tibial nerve stimulation (PTNS) for the treatment of OAB symptoms of urinary urgency, urinary frequency, and urge incontinence. The Company will present a summary of these presentations on Monday, March 3 before the market opens. The schedule for the oral presentation and poster-discussion sessions is as follows:

-- Leslie Wooldridge, MSN, RNCS, GNP.F, BCIA-PMBD, Director of the Bladder

Control Clinic, Hackley Health at the Lakes Women's Center, Muskegon,

Michigan, "Percutaneous Tibial Nerve Stimulation: Revival of an Old

Technology for Treatment of Overactive Bladder," Sunday, March 2, at 8

am, oral presentation

-- Vanessa K. Hardy, WHNP, APN, MSN, Nurse Practitioner, Urogynecology,

Vanderbilt University Medical Center, Nashville, Tennessee,

"Percutaneous Tibial Nerve Stimulator: A Viable Option for Urgency,

Frequency, and Urge Incontinence," Friday, February 29 through

Saturday, March 1, poster presentation

-- Lesbia Candelaria, RN, Winter Park Urology Associates, Orlando,

Florida, "Percutaneous Tibial Nerve Stimulation (PTNS) Treatment for

Overactive Bladder (OAB) Patients in a Community Based Urology

Practice," Friday, February 29 through Saturday, March 1, poster


About the Urgent PC Neuromodulation System

The Urgent PC neuromodulation system is a proprietary, minimally invasive nerve stimulation device designed for office-based treatment of OAB symptoms of urge incontinence, urinary urgency and urinary frequency. Application of neuromodulation therapy targets specific nerve tissue and disrupts the signals that lead to the symptoms of OAB. Uroplasty sells the Urgent PC system in the United States, Canada and countries recognizing the CE mark. Outside of the United States, the Urgent PC is also indicated for the treatment of fecal incontinence.

About Uroplasty, Inc.

Uroplasty, Inc., headquartered in Minnetonka, Minnesota, with wholly-owned subsidiaries in The Netherlands and the United Kingdom, is a medical device company that develops, manufactures and markets innovative proprietary products for the treatment of voiding dysfunctions. Our primary focus is the commercialization of our Urgent PC system, which we believe is the only FDA- approved non-surgical neurostimulation therapy for the treatment of overactive bladder (OAB) symptoms. We also offer Macroplastique(R) Implants, a bulking agent for the treatment of urinary incontinence. Please visit Uroplasty, Inc. at

For Further Information:

Uroplasty, Inc.

David Kaysen, President and CEO, or

Medi Jiwani, Vice President, CFO, and Treasurer,


EVC Group

Julie Huang/Matt Selinger (Investors)


Steve DiMattia/Chris Gale (Media)


SOURCE Uroplasty, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Pathology Reports Good for Breast Cancer Studies
2. Best Practice Database: Complimentary Excerpt of Three Sales Force Excellence Studies
3. Policy Studies Inc. (PSI) Awarded Contract to Operate the Commonwealth of Kentuckys New Hire Reporting Program
4. Akela Pharma receives letter from the FDA regarding its pre-clinical toxicology studies for Fentanyl TAIFUN(R)
5. California Institute of Integral Studies Launches Groundbreaking Community Mental Health Program
6. Stem cell therapy studies for stroke, cerebral palsy prepare for clinical trials
7. UK Center for Tobacco Control Studies to be based in Nottingham
8. Cell division studies hint at future cancer therapy
9. Freeze-dried tendon implants prove effective in early studies
10. Rockefeller Universitys Center for Clinical and Translational Science funds pilot studies
11. ASPS Studies Re-Evaluate Psychological Benefits and Health Concerns of Silicone Breast Implants
Post Your Comments:
(Date:12/1/2015)... Viejo, CA (PRWEB) , ... December 01, 2015 , ... ... length of footage, and with full control over customization, the possibilities are truly endless, ... frame rate, position randomization, overlay depth position, vertical flip, horizontal flip, depth of field ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... receiving the 2015 HSJ Acute Sector Innovation Award on November 18th. This prestigious ... care experience, and propose exciting enhancements to the medical landscape. , The UCLH ...
(Date:11/30/2015)... Cary, NC (PRWEB) , ... November 30, 2015 ... ... Dominique Dawes, Amanda Beard and Brooke Bennett are collaborating with brands across various ... , These four influential figures make up an elite group of Gold Medal ...
(Date:11/30/2015)... , ... December 01, 2015 , ... ... Christina Colon as a 2015-2016 inductee into its VIP Woman of the ... NAPW is the nation’s leading networking organization exclusively for professional women, boasting 850,000 ...
(Date:11/30/2015)... (PRWEB) , ... November 30, 2015 , ... ... programs of the19th Bi-National Convention of the Federation of Philippine American Chambers of ... in Las Vegas, Nevada. , 1Heart Caregiver Services, as an active delegate ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... VERONA, Virginia , 1 de diciembre ... líder en tecnología para cuchillas de precisión, ... un programa de identidad de marca. El ... en el diseño y la ingeniería de ... toda la diferencia". ...
(Date:12/1/2015)... , Dec. 1, 2015 During the ... San Francisco, CA , Medinol ... the coronary marketplace. During a satellite symposium, "The ... Design to Minimize Restenosis", a renowned physician panel ... Medinol NIRxcell™ CoCr Coronary Stent System and the ...
(Date:12/1/2015)... YORK , Dec. 1, 2015 Relmada Therapeutics, ... the treatment of chronic pain, announced today that the company ... will be held December 1-3 at the Luxe Sunset Boulevard ... Sergio Traversa , CEO of Relmada Therapeutics, will present on ... Eastern Time). . Please register at least ...
Breaking Medicine Technology: